ArticleActa obstetricia et gynecologica Scandinavica2025
Association of maternal asthma with congenital heart defects in offspring.
Article in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of maternal asthma with congenital heart defects in offspring.Acta obstetricia et gynecologica Scandinavica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionAsthma is the most common chronic disease among pregnant women. Some studies have linked maternal asthma to an increased risk of congenital malformations, particularly congenital heart defects (CHDs). Among these, ventricular septal defect (VSD) is the most common, accounting for nearly half of all CHD cases. We investigated the association between maternal asthma and the risk of CHD in offspring. As a sensitivity analysis, we also examined the associations between maternal atopic predisposition, maternal use of asthma medication, and CHD risk. MATERIAL AND
methodsThis retrospective, population-based study utilized a comprehensive birth cohort of all singleton births in Finland between 1996 and 2018. Data were derived by linking four high-coverage national health registers.
resultsThe cohort included 1 274 540 eligible mother-child pairs. A total of 106 544 (8.4%) mothers had a diagnosis of asthma or had purchased asthma medication during pregnancy. Of the offspring, 18 772 (1.5%) were diagnosed with a congenital heart defect (CHD), and 8855 (0.7%) had a diagnosis of ventricular septal defect (VSD). Maternal asthma was weakly associated with overall CHD (OR 1.18; 95% CI, 1.12 to 1.24) and with VSD (OR 1.19; 95% CI, 1.10 to 1.27). The association between maternal asthma and CHD was observed in both allergic asthma (OR 1.33; 95% CI, 1.18 to 1.50) and nonallergic asthma (OR 1.27; 95% CI, 1.04 to 1.56). Maternal allergic conditions, such as atopic dermatitis and allergic rhinitis, were also associated with CHD overall (OR 1.13; 95% CI, 1.02 to 1.25) and with VSD (OR 1.20; 95% CI, 1.04 to 1.38).
conclusionsMaternal asthma and allergic tendency are associated with a modestly increased risk of CHD in offspring, particularly VSD. Nonallergic asthma was also linked to CHD, especially right-sided defects. These findings suggest that maternal allergic inflammation may have teratogenic effects during fetal cardiac development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.